From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors

From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors

Aromatase inhibitors (AI) are extensively used as adjuvant endocrine therapy in post-menopausal women with hormone receptor-positive early breast cancer (HR+ EBC), but their impact on bone health is not negligible. This work aimed to assess bone loss, fracture incidence, and risk factors associated...

Full description

Bibliographic Details
Main Authors: Leonor Vasconcelos de Matos, Leonor Fernandes, Maria Teresa Neves, Fátima Alves, Mafalda Baleiras, André Ferreira, Pedro Giesteira Cotovio, Tiago Dias Domingues, Mariana Malheiro, Ana Plácido, Maria Helena Miranda, Ana Martins
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Current Oncology
Subjects:
breast cancer
aromatase inhibitors
osteoporosis
fracture
Online Access:https://www.mdpi.com/1718-7729/28/2/104

Internet

https://www.mdpi.com/1718-7729/28/2/104

Similar Items